Last 7 days
-2.4%
Last 30 days
-6.1%
Last 90 days
-23.3%
Trailing 12 Months
-67.9%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-06-26 | Watson W. Mark | acquired | - | - | 7,375 | - |
2023-06-26 | Yedid Robert A. | acquired | - | - | 7,375 | - |
2023-06-26 | Wheadon David E. | acquired | - | - | 7,375 | - |
2023-06-26 | HERON ELAINE J | acquired | - | - | 6,922 | - |
2023-06-26 | Finney Michael J. | acquired | - | - | 7,375 | - |
2023-06-12 | Lee Phillip E | acquired | - | - | 22,500 | chief financial officer |
2023-03-17 | Floroiu Cezar Andrei | acquired | - | - | 367,735 | president, chief exec officer |
2023-03-17 | Cummings James F. | acquired | - | - | 194,350 | chief medical officer |
2023-03-17 | Lee Phillip E | acquired | - | - | 101,652 | chief financial officer |
2023-03-17 | Lee Phillip E | acquired | - | - | 191,652 | chief financial officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-08-23 | CTC Alternative Strategies, Ltd. | new | - | 8,249 | 8,249 | 0.01% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | sold off | -100 | -36,175 | - | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -1.19 | 229 | 10,867 | -% |
2023-08-16 | Nuveen Asset Management, LLC | sold off | -100 | -1,680,000 | - | -% |
2023-08-15 | HARBOUR INVESTMENTS, INC. | unchanged | - | -40.00 | 1,102 | -% |
2023-08-15 | GOLDMAN SACHS GROUP INC | added | 162 | 161,454 | 266,940 | -% |
2023-08-15 | ALLIANCEBERNSTEIN L.P. | sold off | -100 | -144,605 | - | -% |
2023-08-15 | Belpointe Asset Management LLC | sold off | -100 | -1,864 | - | -% |
2023-08-15 | Rokos Capital Management LLP | new | - | 365,250 | 365,250 | -% |
2023-08-15 | IHT Wealth Management, LLC | reduced | -1.57 | -9,969 | 187,696 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jul 07, 2023 | blackrock inc. | 1.3% | 1,928,709 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 5.35% | 7,019,507 | SC 13G | |
Feb 01, 2023 | blackrock inc. | 6.7% | 8,858,225 | SC 13G/A | |
Jan 10, 2023 | state street corp | 1.83% | 2,398,264 | SC 13G/A | |
Mar 10, 2022 | state street corp | 10.39% | 13,072,021 | SC 13G/A | |
Feb 11, 2022 | state street corp | 8.91% | 11,187,642 | SC 13G/A | |
Feb 07, 2022 | blackrock inc. | 6.7% | 8,452,420 | SC 13G | |
Feb 11, 2021 | state street corp | 8.63% | 9,444,967 | SC 13G | |
Jun 09, 2020 | armistice capital, llc | 19.99% | 16,785,583 | SC 13D/A | |
May 27, 2020 | armistice capital, llc | 11.3% | 8,400,000 | SC 13D/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 06, 2023 | 8-K | Current Report | |
Aug 03, 2023 | 8-K | Current Report | |
Aug 03, 2023 | 10-Q | Quarterly Report | |
Aug 01, 2023 | 4 | Insider Trading | |
Aug 01, 2023 | 4 | Insider Trading | |
Aug 01, 2023 | 4 | Insider Trading | |
Aug 01, 2023 | 4 | Insider Trading | |
Aug 01, 2023 | 4 | Insider Trading | |
Jul 26, 2023 | 8-K | Current Report | |
Jul 10, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AMGN | 145.2B | 26.6B | 4.13% | 21.09% | 18.2 | 5.46 | 0.75% | 21.34% |
GILD | 94.5B | 27.4B | -0.16% | 19.51% | 17.24 | 3.45 | -0.48% | 32.56% |
MRNA | 39.4B | 10.7B | -6.80% | -20.18% | 32.68 | 3.7 | -53.67% | -91.41% |
BIIB | 37.7B | 10.0B | -1.71% | 27.59% | 14.15 | 3.78 | -6.23% | 29.40% |
MID-CAP | ||||||||
NBIX | 11.2B | 1.7B | 5.59% | 6.81% | 63.29 | 6.67 | 29.01% | 1345.90% |
BBIO | 4.5B | - | -3.04% | 140.92% | -7.66 | 48.33 | 54.84% | -12.96% |
DNLI | 3.1B | - | -4.51% | -22.98% | -23.78 | 37.44 | 122.90% | 54.78% |
BEAM | 2.0B | 80.2M | 6.46% | -52.82% | -6.01 | 24.54 | 42.17% | -39.82% |
SMALL-CAP | ||||||||
RCUS | 1.5B | 121.2M | 4.38% | -25.42% | -5.13 | 12.17 | -70.36% | -531.73% |
REPL | 980.2M | 15.3M | -15.63% | 3.04% | -5.4 | 64.02 | 1090.59% | -36.57% |
NVAX | 664.9M | 1.6B | -12.64% | -74.33% | -1.13 | 0.42 | 23.74% | 60.24% |
FATE | 221.7M | - | -17.58% | -90.72% | -1.05 | 1.62 | 116.83% | 16.61% |
SGMO | 146.7M | - | -8.84% | -84.12% | -0.74 | 0.61 | 113.96% | -15.19% |
VXRT | 112.7M | 2.1M | -6.14% | -67.90% | -1.12 | 54.83 | 487.70% | -8.66% |
IBIO | 4.1M | - | -12.28% | -96.10% | -0.05 | 3.21 | - | -129.46% |
-36.7%
-25.3%
-55.1%
100%
100%
100%
Y-axis is the maximum loss one would have experienced if Vaxart was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 90.1% | 2,055,000 | 1,081,000 | 107,000 | 228,333 | 349,667 | 471,000 | 892,000 | 1,174,000 | 1,239,000 | 1,650,000 | 4,046,000 | 7,606,000 | 7,795,000 | 7,848,600 | 7,902,200 | 7,955,800 | 8,009,400 | 8,063,000 | 4,159,000 | 3,152,000 | 3,786,000 |
Operating Expenses | -4.2% | 111,244,000 | 116,080,000 | 114,694,000 | 107,823,000 | 95,848,000 | 82,488,000 | 73,644,000 | 63,072,000 | 53,475,000 | 46,637,000 | 34,216,000 | 30,041,000 | 27,355,000 | 23,388,000 | 25,647,000 | 22,058,000 | 23,051,000 | 26,352,000 | 25,915,000 | 25,562,000 | 22,272,000 |
S&GA Expenses | -12.7% | 25,630,000 | 29,353,000 | 29,386,000 | 28,693,000 | 26,775,000 | 22,604,000 | 21,890,000 | 21,262,000 | 20,410,000 | 19,156,000 | 15,202,000 | 11,407,000 | 8,672,000 | 6,151,000 | 6,187,000 | 6,082,000 | 6,301,000 | 6,697,000 | 6,681,000 | 8,555,000 | 7,505,000 |
R&D Expenses | -1.3% | 81,360,000 | 82,473,000 | 81,054,000 | 76,125,000 | 66,068,000 | 56,879,000 | 48,749,000 | 41,810,000 | 34,017,000 | 28,394,000 | 19,863,000 | 14,563,000 | 13,660,000 | 12,253,000 | 14,540,000 | 15,723,000 | 16,391,000 | 17,696,000 | 17,275,000 | 15,301,000 | 13,167,000 |
EBITDA | 100.0% | - | -100,985,000 | -101,886,000 | -99,422,000 | -88,233,000 | -75,132,000 | -66,155,000 | - | - | -43,681,000 | -29,272,000 | -21,752,000 | -18,734,000 | -14,926,000 | -14,244,000 | -12,679,000 | -13,768,000 | -17,046,000 | - | - | - |
EBITDA Margin | 100.0% | - | -144 | -952 | -625 | -245 | -159 | -74.16 | - | - | -26.47 | -7.23 | -2.86 | -2.40 | -1.90 | -1.80 | -1.59 | -1.72 | -2.11 | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 315,000 | 407,000 | 452,000 | 491,000 | 821,000 | 1,471,000 | 2,110,000 |
Earnings Before Taxes | 6.4% | -100,837,000 | -107,721,000 | -107,691,000 | -104,535,000 | -92,804,000 | -79,475,000 | -70,363,000 | -63,445,000 | -53,942,000 | -46,807,000 | -31,982,000 | -24,367,000 | -21,537,000 | -18,210,000 | -18,155,000 | -16,764,000 | -18,083,000 | -21,329,000 | -17,898,000 | -16,376,000 | -12,001,000 |
EBT Margin | 100.0% | - | -154 | -1,006 | -657 | -258 | -168 | -78.88 | -54.04 | -43.54 | -28.37 | -7.90 | -3.20 | -2.76 | -2.32 | -2.30 | -2.11 | - | - | - | - | - |
Net Income | 6.4% | -100,917,000 | -107,797,000 | -107,758,000 | -104,604,000 | -92,878,000 | -79,564,000 | -70,470,000 | -63,567,000 | -54,069,000 | -46,930,000 | -32,220,000 | -24,768,000 | -21,943,000 | -18,603,000 | -18,645,000 | -17,138,000 | -18,426,000 | -21,660,000 | -18,007,000 | -14,180,000 | -9,805,000 |
Net Income Margin | 100.0% | - | -154 | -1,007 | -657 | -258 | -168 | -79.00 | -54.15 | -43.64 | -28.44 | -7.96 | -3.26 | -2.82 | -2.37 | -2.36 | -2.15 | - | - | - | - | - |
Free Cashflow | 100.0% | - | -103,620,000 | -104,380,000 | -88,156,000 | -87,104,000 | -74,241,000 | -64,989,000 | -59,828,000 | -53,800,000 | -38,968,000 | -24,973,000 | -17,109,000 | -12,001,000 | -11,947,000 | -13,940,000 | -16,033,000 | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -5.5% | 123 | 130 | 154 | 175 | 181 | 200 | 221 | 241 | 229 | 206 | 153 | 155 | 64.00 | 53.00 | 37.00 | 43.00 | 37.00 | 36.00 | 35.00 | 41.00 | 48.00 |
Current Assets | -6.0% | 71.00 | 76.00 | 99.00 | 120 | 138 | 154 | 169 | 192 | 189 | 175 | 129 | 136 | 46.00 | 34.00 | 18.00 | 21.00 | 17.00 | 15.00 | 15.00 | 19.00 | 26.00 |
Cash Equivalents | -10.6% | 43.00 | 48.00 | 46.00 | 51.00 | 91.00 | 123 | 144 | 167 | 165 | 157 | 127 | 133 | 44.00 | 30.00 | 14.00 | 20.00 | 16.00 | 8.00 | 12.00 | 18.00 | 24.00 |
Net PPE | -3.2% | 14.00 | 14.00 | 16.00 | 12.00 | 9.00 | 8.00 | 7.00 | 5.00 | 4.00 | 2.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 1.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 |
Goodwill | 0% | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Liabilities | -6.3% | 38.00 | 40.00 | 43.00 | 53.00 | 38.00 | 34.00 | 34.00 | 36.00 | 29.00 | 30.00 | 29.00 | 23.00 | 24.00 | 21.00 | 24.00 | 24.00 | 21.00 | 24.00 | 24.00 | 25.00 | 25.00 |
Current Liabilities | -11.5% | 14.00 | 16.00 | 18.00 | 22.00 | 16.00 | 11.00 | 11.00 | 13.00 | 13.00 | 12.00 | 12.00 | 10.00 | 11.00 | 7.00 | 9.00 | 9.00 | 7.00 | 9.00 | 7.00 | 8.00 | 9.00 |
Shareholder's Equity | -5.2% | 85.00 | 90.00 | 111 | 122 | 143 | 166 | 188 | 205 | 200 | 176 | 123 | 132 | 40.00 | 31.00 | 13.00 | 19.00 | 16.00 | 13.00 | 11.00 | 16.00 | 22.00 |
Retained Earnings | -6.4% | -374 | -352 | -327 | -303 | -273 | -244 | -219 | -198 | -181 | -164 | -148 | -135 | -126 | -117 | -116 | -110 | -104 | -99.35 | -97.99 | -93.09 | -86.54 |
Additional Paid-In Capital | 4.0% | 460 | 442 | 438 | 426 | 417 | 411 | 407 | 404 | 381 | 341 | 272 | 267 | 167 | 142 | 130 | 125 | 119 | 111 | 109 | 108 | 108 |
Shares Outstanding | 12.1% | 152 | 136 | 134 | 128 | 126 | 126 | 126 | 124 | 121 | 115 | 110 | 108 | 68.00 | 61.00 | 22.00 | 13.00 | 11.00 | 7.00 | 6.00 | 6.00 | 5.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 9.0% | -85.70 | -94.13 | -94.78 | -81.44 | -81.09 | -68.35 | -59.83 | -54.78 | -49.77 | -37.13 | -23.75 | -16.78 | -11.85 | -11.64 | -13.09 | -15.00 | -16.03 | -8.61 | -14.55 | -13.55 | -12.69 |
Share Based Compensation | 3.9% | 14.00 | 13.00 | 14.00 | 13.00 | 12.00 | 11.00 | 9.00 | 6.00 | 5.00 | 6.00 | 4.00 | 4.00 | 3.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Cashflow From Investing | 554.9% | 9.00 | 1.00 | -20.41 | -44.39 | -17.73 | -24.81 | -49.10 | -41.82 | -37.72 | -21.78 | -1.22 | -0.33 | -0.15 | -0.30 | -0.85 | -1.03 | -1.08 | -1.12 | 26.00 | 41.00 | 47.00 |
Cashflow From Financing | 62.0% | 29.00 | 18.00 | 17.00 | 9.00 | 25.00 | 59.00 | 126 | 130 | 208 | 186 | 138 | 131 | 40.00 | 33.00 | 16.00 | 18.00 | 9.00 | 1.00 | -1.73 | -1.61 | -1.48 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue from Contract with Customer, Including Assessed Tax | $ 1,358 | $ 0 | $ 2,033 | $ 85 |
Operating expenses: | ||||
Research and development | 18,813 | 19,926 | 38,435 | 38,129 |
General and administrative | 5,598 | 9,321 | 12,223 | 15,979 |
Total operating expenses | 24,411 | 29,247 | 50,658 | 54,108 |
Operating loss | (23,053) | (29,247) | (48,625) | (54,023) |
Other income (expense): | ||||
Interest income | 711 | 157 | 1,353 | 192 |
Non-cash interest expense related to sale of future royalties | (188) | (323) | (366) | (663) |
Foreign exchange loss, net | (1) | (2) | (4) | (2) |
Loss before income taxes | (22,531) | (29,415) | (47,642) | (54,496) |
Provision for income taxes | 19 | 15 | 48 | 35 |
Net loss | $ (22,550) | $ (29,430) | $ (47,690) | $ (54,531) |
Net loss per share - basic and diluted (in dollars per share) | $ (0.16) | $ (0.23) | $ (0.35) | $ (0.43) |
Shares used to compute net loss per share - basic and diluted (in shares) | 139,594,238 | 126,428,298 | 137,403,416 | 126,111,777 |
Comprehensive loss: | ||||
Net loss | $ (22,550) | $ (29,430) | $ (47,690) | $ (54,531) |
Unrealized gain (loss) on available-for-sale investments, net of tax | 46 | (100) | 275 | (335) |
Comprehensive loss | (22,504) | (29,530) | (47,415) | (54,866) |
Non Cash Royalty Revenue [Member] | ||||
Revenue from Contract with Customer, Including Assessed Tax | 30 | 0 | 308 | 85 |
Grant [Member] | ||||
Revenue from Contract with Customer, Including Assessed Tax | $ 1,328 | $ 0 | $ 1,725 | $ 0 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash, cash equivalents and restricted cash | $ 43,277 | $ 46,013 |
Short-term investments | 24,628 | 49,704 |
Accounts receivable | 29 | 20 |
Prepaid expenses and other current assets | 3,327 | 3,714 |
Total current assets | 71,261 | 99,451 |
Property and equipment, net | 13,918 | 15,585 |
Right-of-use assets, net | 26,804 | 25,715 |
Intangible assets, net | 4,654 | 5,020 |
Goodwill | 4,508 | 4,508 |
Other long-term assets | 1,508 | 3,568 |
Total assets | 122,653 | 153,847 |
Current liabilities: | ||
Accounts payable | 4,199 | 5,514 |
Deferred grant revenue | 275 | 2,000 |
Other accrued current liabilities | 6,050 | 8,084 |
Current portion of operating lease liability | 2,430 | 2,228 |
Current portion of liability related to sale of future royalties | 929 | 95 |
Total current liabilities | 13,883 | 17,921 |
Operating lease liability, net of current portion | 18,566 | 19,477 |
Liability related to sale of future royalties, net of current portion | 4,869 | 5,621 |
Other long-term liabilities | 262 | 231 |
Total liabilities | 37,580 | 43,250 |
Commitments and contingencies (Note 8) | ||
Stockholders’ equity: | ||
Preferred stock: $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of June 30, 2023 and December 31, 2022 | 0 | 0 |
Common stock: $0.0001 par value; 250,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 152,016,238 shares issued and 151,982,992 shares outstanding as of June 30, 2023 and 134,199,429 shares issued and outstanding as of December 31, 2022. | 15 | 13 |
Additional paid-in capital | 459,912 | 437,992 |
Treasury stock at cost, 33,246 shares and none as of June 30, 2023 and December 31, 2022, respectively | (31) | 0 |
Accumulated deficit | (374,799) | (327,109) |
Accumulated other comprehensive loss | (24) | (299) |
Total stockholders’ equity | 85,073 | 110,597 |
Total liabilities and stockholders’ equity | $ 122,653 | $ 153,847 |